# Imaging Regional Lung Defect Severity

> **NCT01640288** · PHASE1,PHASE2 · COMPLETED · sponsor: **Hal C Charles** · enrollment: 171 (actual)

## Conditions studied

- COPD

## Interventions

- **DRUG:** Perfluorinated Gas/Oxygen Mixture
- **OTHER:** High Resolution CT of the Chest

## Key facts

- **NCT ID:** NCT01640288
- **Lead sponsor:** Hal C Charles
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2018-08-10
- **Final completion:** 2018-08-10
- **Target enrollment:** 171 (ACTUAL)
- **Last updated:** 2020-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01640288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01640288, "Imaging Regional Lung Defect Severity". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01640288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*